Satellos Bioscience Inc. (MSCLF)
OTCMKTS
· Delayed Price · Currency is USD
0.4390
+0.0260 (6.30%)
Jul 11, 2025, 4:00 PM EDT
Satellos Bioscience Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
74.70M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
Satellos Bioscience News
- 24 days ago - Satellos Bioscience Shareholders Elect Two New Board Members - Business Wire
- 24 days ago - Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders - Business Wire
- 27 days ago - Satellos Bioscience to Participate in PPMD's Annual Conference in Las Vegas - Business Wire
- 7 weeks ago - Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy - Business Wire
- 7 weeks ago - Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants - Newsfile Corp
- 2 months ago - Satellos Reports First Quarter 2025 Results and Highlights Recent Company Progress - Business Wire
- 2 months ago - Satellos to Present at the CureDuchenne FUTURES National Conference - Business Wire
- 2 months ago - Satellos to Present at Bloom Burton & Co. Healthcare Investor Conference - Business Wire